A Case of Metaplastic Breast Cancer With Prolonged Response to Single Agent Liposomal Doxorubicin

Cureus
doi 10.7759/cureus.454
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cureus, Inc.

Related search

A Case of Resectable Cervical Lymph-Node Metastasis of Metaplastic Breast Cancer

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2012English

Efficacy and Safety of Non-Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer Therapy

OnCOReview
Oncology
2017English

Multicenter Experience of Nonpegylated Liposomal Doxorubicin Use in the Management of Metastatic Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2014English

Metaplastic Breast Cancer: To Radiate or Not to Radiate?

Annals of Surgical Oncology
OncologySurgery
2010English

Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer

PLoS ONE
Multidisciplinary
2013English

New Approaches in the Management of Advanced Breast Cancer &Ndash; Role of Combination Treatment With Liposomal Doxorubicin

Breast Cancer: Targets and Therapy
Oncology
2009English

A High Response Rate to Liposomal Doxorubicin Is Seen Among Women With BRCA Mutations Treated for Recurrent Epithelial Ovarian Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2011English

Lyso-Thermosensitive Liposomal Doxorubicin for Treatment of Bladder Cancer

International Journal of Hyperthermia
MedicineCancer ResearchRadiologicalPhysiologyUltrasound Technology
2017English

Clinicopathological Study of Epithelial Metaplastic Breast Cancer

Journal of Cancer Therapy
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy